TransDigm Group's recent acquisitions of Stellant Systems and Jet Parts Engineering, totaling over $3 billion, have analysts debating whether the moves solidify its lucrative aftermarket strategy or stretch its leveraged balance sheet too thin ahead of a critical earnings season.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
Two of the largest known Ethereum holders, BitcoinOG and Trend Research, have strategically sold a combined $371 million worth of ETH to repay loans on the Aave protocol. This voluntary deleveraging, distinct from over $140 million in automated liquidations processed by Aave, highlights a shift towards caution among major crypto players amid market volatility.
After weeks of closure, the vital Rafah border crossing between Gaza and Egypt is set to resume limited operations, facilitating the movement of urgent humanitarian cases and some foreign nationals.
In a landmark deal set to reshape global aluminum supply chains, Aluminum Corporation of China (Chalco) and mining giant Rio Tinto have jointly acquired a controlling interest in Brazil's Companhia Brasileira de Alumínio (CBA). This strategic move marks Chalco's largest overseas investment to date, significantly expanding its international footprint and influence.
Slovakia’s top national security adviser has resigned following the release of newly unsealed court documents linking him to email exchanges with Jeffrey Epstein. The adviser denies any wrongdoing, stating the move aims to shield the prime minister from political fallout.
The research and advisory giant is expected to post modest revenue growth when it reports Tuesday morning, as investors weigh its performance against a mixed backdrop for IT services firms.
A San Antonio family's morning commute turned to terror when a driver, angered by a brief honk, opened fire on their vehicle, critically wounding a child in the backseat.
Newly unsealed records in the double homicide of Monique and Spencer Tepe allege a pattern of abuse and premeditation by the ex-husband now charged with their murders, painting a grim picture of events leading to the December attack.
The Walt Disney Company's board is reportedly finalizing its choice for the next chief executive, with Josh D’Amaro, the chairman of its highly profitable parks and experiences division, poised to take the helm. The decision would conclude a lengthy succession search and mark a pivotal leadership transition for the global entertainment giant.
Nvidia is set to make a landmark investment in OpenAI's latest funding round, CEO Jensen Huang confirmed, signaling a deepening alliance between the AI hardware giant and the leading AI research lab. However, reports of internal skepticism at Nvidia introduce uncertainty into the final terms and timing of the deal.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
With shares languishing near $5.74, Bausch Health Companies (BHC) presents a stark valuation puzzle. While a standard DCF model suggests a staggering 91% undervaluation, the market's persistent sell-off reflects deep-seated concerns over the company's restructuring path and debt burden. We examine the numbers behind the divergence.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.
As earnings season unfolds, Apple and Meta Platforms both posted impressive results, but their paths diverge sharply. Apple's growth reaccelerates on iPhone strength, while Meta's robust outlook is shadowed by soaring AI investments. The debate over which stock offers the better value is heating up.
The planned acquisition of craft beverage distributor Point Blank by industry giant Columbia Distributing will result in the closure of two Oregon facilities and impact 177 workers, despite assurances of a 'seamless' transition for partners.
Fueled by AI-driven ad innovations and surging social media engagement, Meta's advertising revenue is on track to surpass Google Search in 2024, marking a historic shift in the digital landscape.
Expedia Group's latest quarterly results, surpassing expectations across key metrics, have reignited investor interest and a fierce debate over its true worth. While analysts see room for growth, looming challenges in travel demand and disruptive AI search tools cloud the horizon.
The U.S. Air Force Research Laboratory has awarded Palladyne AI a contract for its HANGTIME project, marking a significant expansion of the company's autonomous swarm software from ground and air assets into the space domain. The deal validates the company's core technology but comes as investors weigh its growth potential against ongoing financial challenges.
